Squarepoint’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,799
| Closed | -$780K | – | 3656 |
|
|
2022
Q2 | $780K | Buy |
+23,799
| New | +$752K | ﹤0.01% | 1759 |
|
|
2022
Q1 | – | Sell |
-10,554
| Closed | -$250K | – | 3828 |
|
|
2021
Q4 | $250K | Sell |
10,554
-9,133
| -46% | -$225K | ﹤0.01% | 2559 |
|
|
2021
Q3 | $494K | Buy |
19,687
+1,113
| +6% | +$28.4K | ﹤0.01% | 1972 |
|
|
2021
Q2 | $483K | Buy |
18,574
+2,741
| +17% | +$74.6K | ﹤0.01% | 2154 |
|
|
2021
Q1 | $405K | Buy |
15,833
+3,298
| +26% | +$84.5K | ﹤0.01% | 2181 |
|
|
2020
Q4 | $251K | Buy |
12,535
+624
| +5% | +$12.2K | ﹤0.01% | 2357 |
|
|
2020
Q3 | $204K | Sell |
11,911
-7,042
| -37% | -$133K | ﹤0.01% | 2082 |
|
|
2020
Q2 | $414K | Sell |
18,953
-9,928
| -34% | -$227K | 0.01% | 1408 |
|
|
2020
Q1 | $668K | Sell |
28,881
-2,776
| -9% | -$80.7K | 0.02% | 892 |
|
|
2019
Q4 | $1.04M | Sell |
31,657
-8,520
| -21% | -$273K | 0.01% | 1305 |
|
|
2019
Q3 | $1.28M | Sell |
40,177
-20,649
| -34% | -$602K | 0.01% | 1064 |
|
|
2019
Q2 | $1.56M | Buy |
+60,826
| New | +$1.55M | 0.02% | 987 |
|
|
2018
Q1 | – | Sell |
-11,463
| Closed | -$438K | – | 2306 |
|
|
2017
Q4 | $438K | Buy |
+11,463
| New | +$458K | 0.01% | 1288 |
|
|
2017
Q3 | – | Sell |
-14,164
| Closed | -$528K | – | 1970 |
|
|
2017
Q2 | $528K | Buy |
14,164
+5,057
| +56% | +$183K | 0.01% | 931 |
|
|
2017
Q1 | $357K | Sell |
9,107
-17,751
| -66% | -$666K | 0.01% | 1012 |
|
|
2016
Q4 | $935K | Buy |
+26,858
| New | +$1.05M | 0.04% | 534 |
|
Other funds holding NTUS
Squarepoint's NTUS Position: Q3 2022 in Review
Squarepoint sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 23,799 shares — an estimated $780K sold.
Squarepoint first reported a position in NTUS in Q4 2016 and held it in 16 quarters. The position peaked at $1.56M in Q2 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Squarepoint reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Squarepoint sold 23,799 Natus Medical Inc shares in Q3 2022, an estimated $780K.
- Squarepoint first reported a position in Natus Medical Inc in Q4 2016 and held it in 16 quarters.
- Squarepoint's Natus Medical Inc position peaked at $1.56M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.